Literature DB >> 24314172

Factors influencing jaundice-free survival with the native liver in post-portoenterostomy biliary atresia patients: results from a single institution.

Hiroyuki Koga1, Momoko Wada, Hiroki Nakamura, Go Miyano, Manabu Okawada, Geoffrey J Lane, Tadaharu Okazaki, Atsuyuki Yamataka.   

Abstract

PURPOSE: We reviewed post-portoenterostomy (PE) biliary atresia (BA) patients who became "jaundice-free" (JF; total bilirubin (T-bil) ≤1.2 mg/dL) to determine factors associated with survival with the native liver (SNL).
METHODS: We reviewed 76 BA patients treated by PE at our institute between 1989, when liver transplantation (LTx) became available in Japan, and 2012, prospectively. Of these, 60 who became JF and remained JF were divided into two groups, SNL (n=44) and LTx (n=16). Age and weight at PE, pre- and post-PE T-bil, AST, γ-GT, time taken to become JF, corticosteroid requirements, incidence of cholangitis, and micro-bile duct size were compared between the two groups.
RESULTS: The SNL patients became JF significantly earlier: 58 vs. 115 days (p<.05). Corticosteroid requirement, cholangitis, and postoperative AST/γ-GT were significantly lower in the SNL patients (p<.05). SNL was significantly higher if patients became JF ≤60 days post-PE (p<.01). LTx was performed from 0.5 to 11 years post-PE (mean=3.4). All patients who had cholangitis within 3 months of PE eventually required LTx (p<.05).
CONCLUSIONS: Becoming JF ≤60 days post-PE would appear to be a factor associated with SNL, while cholangitis within 3 months of PE would appear to be associated with LTx. Elevation of AST and γ-GT would also appear to be early indicators of risk for LTx during follow-up of JF patients after successful PE.
© 2013.

Entities:  

Keywords:  Biliary atresia; Jaundice-free; Liver transplantation; Portoenterostomy; Survival with native liver

Mesh:

Year:  2013        PMID: 24314172     DOI: 10.1016/j.jpedsurg.2013.08.007

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  16 in total

1.  Clinical and pathological features of patients with biliary atresia who survived for more than 5 years with native liver.

Authors:  Song Sun; Shan Zheng; Xuexin Lu; Gong Chen; Yangyang Ma; Lian Chen; Kuiran Dong
Journal:  Pediatr Surg Int       Date:  2018-02-09       Impact factor: 1.827

2.  Classification of biliary atresia in the laparoscopic era.

Authors:  Hiroki Nakamura; Naruhiko Murase; Hiroyuki Koga; Joel Cazares; Geoffrey J Lane; Hiroo Uchida; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2016-09-21       Impact factor: 1.827

Review 3.  Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change?

Authors:  Mark Davenport
Journal:  Pediatr Surg Int       Date:  2017-09-22       Impact factor: 1.827

4.  Prognostic values of serum bilirubin at 7th day post-Kasai for survival with native livers in patients with biliary atresia.

Authors:  Sinobol Chusilp; Paiboon Sookpotarom; Kanokan Tepmalai; Prapapan Rajatapiti; Voranush Chongsrisawat; Yong Poovorawan; Paisarn Vejchapipat
Journal:  Pediatr Surg Int       Date:  2016-07-30       Impact factor: 1.827

5.  Preventive effect of prophylactic intravenous antibiotics against cholangitis in biliary atresia: a randomized controlled trial.

Authors:  Gong Chen; Jia Liu; YanLei Huang; Ying Wu; XueXin Lu; Rui Dong; Zhen Shen; Song Sun; Jingying Jiang; Shan Zheng
Journal:  Pediatr Surg Int       Date:  2021-05-19       Impact factor: 1.827

6.  Does time taken to achieve jaundice-clearance influence survival of the native liver in post-Kasai biliary atresia?

Authors:  Hideaki Nakajima; Hiroyuki Koga; Manabu Okawada; Hiroki Nakamura; Geoffrey James Lane; Atsuyuki Yamataka
Journal:  World J Pediatr       Date:  2018-03-26       Impact factor: 2.764

7.  Design and validation of an early scoring system for predicting early outcomes of type III biliary atresia after Kasai's operation.

Authors:  Chen Zhen; Qiao Guoliang; Ma Lishuang; Zhang Zhen; Wang Chen; Zhang Jun; Liu Shuli; Guan Kaoping; Liu Chao; Yang Xuan; Li Long
Journal:  Pediatr Surg Int       Date:  2015-04-18       Impact factor: 1.827

Review 8.  Adjuvant steroid treatment following Kasai portoenterostomy and clinical outcomes of biliary atresia patients: an updated meta-analysis.

Authors:  Min-Zhong Zhang; Peng-Cheng Xun; Ka He; Wei Cai
Journal:  World J Pediatr       Date:  2016-10-15       Impact factor: 2.764

9.  Study protocol of Phase 2 open-label multicenter randomized controlled trial for granulocyte-colony stimulating factor (GCSF) in post-Kasai Type 3 biliary atresia.

Authors:  Hoa Pham Anh Nguyen; Jinma Ren; Marilyn Butler; Henri Li; Saqib Qazi; Kamran Sadiq; Hieu Trung Dao; AiXuan Holterman
Journal:  Pediatr Surg Int       Date:  2022-04-07       Impact factor: 1.827

10.  Comprehensive assessment of prognosis after laparoscopic portoenterostomy for biliary atresia.

Authors:  Hiroki Nakamura; Hiroyuki Koga; Joel Cazares; Tadaharu Okazaki; Geoffrey J Lane; Go Miyano; Manabu Okawada; Takashi Doi; Masahiko Urao; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2015-10-31       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.